Vinva Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.3M Sell
256,254
-69,690
-21% -$8.05M 0.38% 76
2025
Q4
$34.6M Buy
325,944
+89,400
+38% +$8.39M 0.43% 57
2025
Q3
$18.6M Buy
236,544
+50,206
+27% +$4.14M 0.36% 66
2025
Q2
$14.7M Buy
186,338
+54,898
+42% +$4.36M 0.38% 66
2025
Q1
$11.7M Buy
131,440
+1,170
+0.9% +$109K 0.47% 48
2024
Q4
$12.8M Buy
130,270
+12,316
+10% +$1.27M 0.49% 40
2024
Q3
$13.4M Buy
117,954
+13,910
+13% +$1.65M 0.57% 31
2024
Q2
$13.5M Buy
104,044
+7,093
+7% +$914K 0.68% 23
2024
Q1
$12.8M Buy
96,951
+8,900
+10% +$1.1M 0.72% 21
2023
Q4
$9.58M Buy
88,051
+13,058
+17% +$1.36M 0.65% 26
2023
Q3
$7.82M Sell
74,993
-985
-1% -$106K 0.73% 28
2023
Q2
$8.63M Sell
75,978
-8,987
-11% -$1.02M 0.74% 27
2023
Q1
$9M Buy
+84,965
New +$9.17M 0.75% 24

Other funds holding MRK

Vinva Investment Management's MRK Position: Q1 2026 in Review

Vinva Investment Management reduced its Merck (MRK) stake by 21% in Q1 2026, selling an estimated $8.05M and leaving 256,254 shares worth $30.3M. The position accounts for 0.38% of the portfolio, ranked #76.

Vinva Investment Management first reported a position in MRK in Q1 2023 and has held it in 13 quarters since. The position peaked at $34.6M in Q4 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Vinva Investment Management held 256,254 shares of Merck worth $30.3M as of Q1 2026.
  • Vinva Investment Management sold 69,690 Merck shares in Q1 2026, an estimated $8.05M.
  • Merck made up 0.38% of Vinva Investment Management's portfolio in Q1 2026, its #76 holding.
  • Vinva Investment Management first reported a position in Merck in Q1 2023 and has held it in 13 quarters since.
  • Vinva Investment Management's Merck position peaked at $34.6M in Q4 2025.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.